Apr 21, 2025 04:10PM

Apr 7, 2025 12:55PM

Apr 5, 2025 01:11PM

Apr 4, 2025 12:35PM

Apr 3, 2025 04:00PM

Apr 3, 2025 08:00AM

Apr 2, 2025 04:04PM NMRA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class A

Apr 1, 2025 08:35PM

Apr 1, 2025 01:55PM

Mar 31, 2025 08:30PM

Mar 30, 2025 08:00AM

Mar 29, 2025 04:32PM

Mar 28, 2025 04:32PM

Mar 28, 2025 04:00PM NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 27, 2025 04:27PM

Mar 27, 2025 11:18AM

Mar 26, 2025 04:22PM

Mar 26, 2025 08:00AM

Mar 24, 2025 04:13PM

Mar 23, 2025 04:00PM

Mar 23, 2025 02:02PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 22, 2025 12:23PM

Mar 21, 2025 12:18PM

Mar 19, 2025 07:07PM

Mar 18, 2025 07:02PM

Mar 17, 2025 06:56PM

Mar 17, 2025 04:00PM

Mar 17, 2025 02:27PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 16, 2025 06:57PM

Mar 15, 2025 06:57PM

Mar 14, 2025 06:52PM

Mar 11, 2025 09:40PM

Mar 11, 2025 04:00PM

Mar 10, 2025 05:18PM

Mar 10, 2025 01:44PM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 7, 2025 10:21PM

Mar 5, 2025 05:18PM

Mar 5, 2025 04:00PM

Mar 4, 2025 06:00PM

Mar 4, 2025 05:13PM

Mar 4, 2025 09:33AM

Mar 2, 2025 08:29PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 1, 2025 08:29PM

Feb 28, 2025 08:24PM

Feb 28, 2025 01:54PM

Feb 27, 2025 08:19PM

Feb 27, 2025 04:00PM

Feb 26, 2025 08:14PM

Feb 25, 2025 08:09PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 25, 2025 11:10AM

118,853 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All